Henry Schein delivered a positive second quarter, with results exceeding Wall Street’s expectations and earning a strong market response. Management attributed the outperformance to accelerating internal sales growth, robust gains in its global dental merchandise segment, and early benefits from value creation initiatives. CEO Frederick Lowery emphasized the company’s success in converting occasional buyers into engaged customers and highlighted strong market share gains, particularly in the U.S. and Canada. The company also cited the expansion of its Henry Schein One technology platform and growth in its own-brand and specialty products as key contributors to the quarter’s momentum.

Is now the time to buy HSIC? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Henry Schein’s Q2 Earnings Call

• Jeffrey Johnson (Baird) asked about the sustainability of U.S. dental consumables growth. CEO Frederick Lowery explained that recent growth was more price-driven than volume-based and credited successful promotions converting episodic buyers into regular customers.
• Jason Bednar (Piper Sandler) pressed on the timing and recognition of value creation benefits. CFO Ronald South responded that most operating income improvements from these initiatives would materialize in the second half, especially Q3 and Q4.
• Elizabeth Anderson (Evercore ISI) inquired about the split of gross margin improvements and prospects in specialty categories. Lowery highlighted dynamic pricing, own-brand expansion, and anticipated greater growth in value implants due to the S.I.N. 360 acquisition.
• Jonathan Block (Stifel) sought clarity on U.S. dental equipment trends versus traditional and digital segments. Lowery and South confirmed expected growth for the remainder of the year, supported by a healthy backlog and modest gains in digital equipment, particularly scanners.
• Kevin Caliendo (UBS) questioned why specialty growth was stronger in Europe than in the U.S. Lowery attributed this to differing market dynamics, with the U.S. market being more consumer-driven and slower-growing than Europe.

Catalysts in Upcoming Quarters

Going forward, the StockStory team will watch (1) the pace of AI-enabled technology adoption and its impact on recurring revenue, (2) realization of targeted value creation and cost savings, especially as outsourcing and procurement initiatives expand, and (3) further gains in specialty dental and Home Solutions medical segments. Continued execution on portfolio optimization and integration of new leadership structures will also be critical markers for progress.

Henry Schein currently trades at $88.07, up from $86.51 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.